Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of remifentanil on reversal of capsaicin-induced hyperalgesia
2008-003605-13Phase 4Completed
- Sponsor
- Medical University of Vienna, University Clinic for Anesthesiology, General
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of remifentanil in hyperalgesia, sponsored by Medical University of Vienna, University Clinic for Anesthesiology, General. Primary endpoint: Area of pin prick hyperalgesia at 6 hours after remifentanil stop. Started Aug 2008; status: completed.
02
Drugs
remifentanil
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on 2008-003605-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003605-13.